REQUEST FOR PROPOSALS FOR BLOOD-BASED BIOMARKER DEVELOPMENT
Up to $250,000/year for 2 years - May 1, 2026 (LOI); July 1, 2026 (full application)
Friedreich's Ataxia Research Alliance (FARA)FARA is soliciting proposals focused on discovering and validating bloodbased biomarkers for FA. The initiative aims to identify biologically meaningful, frataxin- downstream monitoring biomarkers that can track disease progression and therapeutic response.
